Method of generating islet beta-cells from exocrine...

Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S325000

Reexamination Certificate

active

07604991

ABSTRACT:
The present invention discloses an in vitro method wherein mammalian beta-cell differentiation can be induced in dedifferentiated exocrine pancreatic cells in a medium comprising ligands of the EGF receptor and the GP130 receptor, such as EGF and LIF. Insulin secreting cells, obtainable by this method, provide a means for the treatment of diabetes by islet transplantation.

REFERENCES:
patent: 6815203 (2004-11-01), Bonner-Weir et al.
patent: 2002/0155598 (2002-10-01), Kerr-Conte et al.
patent: 2006/0122104 (2006-06-01), Presnell et al.
patent: WO 01/32839 (2001-05-01), None
European Search Report dated Nov. 16, 2007 relating to European Application EP 04 73 7673.
Ramiya K. Vijayakumakumar et al. “Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells”,Nature Medicine, Nature America, vol. 6, No. 3, Mar. 2000 pp. 278-282, XP000864764.
Hirosato Mashima et al., “Betacellulin and Activin A Coordinately Convert Amylase-secreting Pancreatic AR42J Cells into insulin-secreting Cells”,Journal of Clinical Investigation, vol.97, No. 7, Apr. 1, 1996, pp. 1647-1657, XP000670303.
Ki-Ho Song et al., “In vitro transdifferentiation of adult pancreatic acinar cells into insulin-expressing cells”,Biochemical and Biophysical Research Communications, vol. 316, No. 4, Apr. 16, 2004, pp. 1094-1100, XP004496901.
Yelena Guz et al., “Regeneration of Pancreatic β Cells from Intra-Islet Precursor Cells in an Experimental Model of Diabetes”,Endocrinology, vol. 142, No. 11, Nov. 2001, pp. 4956-4968, (available at http://www.endo.endojournals.org).
I. Rooman et al., Modulation of rat pancreatic acinoductal transdifferentiation and expression of PDX-1 in vitro,Diabetologia, Springer-Velag 2000, vol. 43, pp. 907-914.
Ilse Rooman et al., “Mitogenic Effect of Gastrin and Expression of Gastrin Receptors in Duct-like Cells of Rat Pancreas”,Gastroenterology, vol. 123, 2001, pp. 940-949.
Ilse Rooman et al., Gastrin Stimulates β Cell Neogenesis and Increases Islet Mass From Transdifferentiated but Not From Normal Exocrine Pancreas Tissue,Diabetes, vol. 51, Mar. 2002, pp. 686-690.
Danling Gu et al., “Endocrine/Exocrine Intermediate Cells in Streptozolocin-Treated INS-IFN-γ Transgenic Mice”,Biomedische Bibl, vol. 15, No. 3, 1997, pp. 246-250.
Yuehua Jiang et al., “Pluripotency of mesenchymal stem cells derived from adult marrow”,Nature, vol. 418, Jul. 2002, pp. 41-49.
Corentin Cras-Méneur et al., “Epidermal Growth Factor Increases Undifferentiated Pancreatic Embryonic Cells In Vitro: A Balance Between Proliferation and Differentiation”,Diabetes, vol. 50, Jul. 2001, pp. 1571-1579.
Päivi J. Miettinan et al., “Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors”,Development, vol. 127, 2000, pp. 2617-2627.
Koji Yamamoto et al., “Recombinant Human Betacellulin Promotes the Neogenesis of β-Cells and Ameliorates Glucose Intolerance in Mice With Diabetes Induced by Selective Alloxan Perfusion”,Diabetes, vol. 40, Dec. 2000, pp. 2021-2027.
Eugenio Bertelli et al., “Intermediate endocrine-acinar pancreatic cells in duct ligation conditions”,American Physiological Society, vol. 273, 1997, pp. 1641-1649.
Susan Bonner-Weir et al., In vitro cultivation of human islets from expanded ductal tissue,PNAS, vol. 97, No. 14, Jul. 5, 2000, pp. 7999-8004.
Luc Bowens, “Transdifferentiation Versus Stem Cell Hypothesis for the Regeneration of Islet Beta-Cells in the Pancreas”,Microscopy Research And Technique, vol. 43, 1998, pp. 332-336.
Luc Bowens et al., “Islet cell neogenesis in the pancreas”,Biomedische-Bibl, 1996, vol. 427, pp. 553-560.
Stephen J. Brand et al., “Pharmacological Treatment of Chronic diabetes by Stimulating Pancreatic β-Cell Regeneration with Systemic Co-administration of EGF and Gastrin”,Pharmaeology & Toxicology, vol. 91, 2000, pp. 414-420.
Jean Buteau et al., “Glucagon-Like Peptide 1 Induces Pancreatic β-Cell Proliferation Via Transactivation of t he Epidermal Growth Factor Receptor”,Diabetes, vol. 52, Jan. 2003, pp. 124-132.
Daniel C. Drucker, “Glucagon-Like Peptides: Regulators of Cell Proliferation, Differentiation, and Apoptosis”,Molecular Endocrinology, vol. 17, No. 2, 2003, pp. 151-171.
Helena Edlund, “Pancreatic Organogenesis—Developmental Mechanisms and Implications for Therapy”,Reviews, vol. 3, Jul. 2002, pp. 524-532.
Viti Jane et al: “Epidermal Growth Factor Receptors Control Competence to Interpret Leukemia Inhibitory Factor as an Astrocyte Inducer in Developing Corex.” The Journal of Neuroscience: The Official Journal of the Society for Neuroscience. Apr. 15, 2003, vol. 23, No. 8, Apr. 15, 2003, pp. 3385-3393, XP002299605.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of generating islet beta-cells from exocrine... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of generating islet beta-cells from exocrine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of generating islet beta-cells from exocrine... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4129743

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.